Combined radioligand therapy and immunotherapy for cancer: research advances and translational challenges

Sen Wang, Shoujun Tang, Shengjie Tang, Chun Wang, Junjie Wang, Yunlong Yang, Yang Yang, Chengkuan Liu, Jiang Fu, Haining Zhou · 2026

Read Combined radioligand therapy and immunotherapy for cancer: research advances and translational challenges by Sen Wang, Shoujun Tang, Shengjie Tang, Chun Wang, Junjie Wang, Yunlong Yang, Yang Yang, Chengkuan Liu, Jiang Fu, Haining Zhou (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13618075.txt.

Description

Sen Wang, Haining Zhou, and eight co-authors review pairing targeted radiation with immunotherapy for cancer. Their review, from twenty twenty-six, covers radioligand therapy. A tagged molecule carries a radioactive payload straight to tumor targets. The method already serves prostate and nerve-type tumors well in clinics.

Radiation kills tumor cells directly, but it may also wake the immune system. Dying cells spill signals that help immune cells spot the tumor. Checkpoint drugs then free T cells to attack. Lab models show the pair can outdo either alone. Human proof is still early, the authors stress. Their review follows the chain from mechanism to clinic.

Catalog record

CREATORSen Wang, Shoujun Tang, Shengjie Tang, Chun Wang, Junjie Wang, Yunlong Yang, Yang Yang, Chengkuan Liu, Jiang Fu, Haining Zhou
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE48 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13618075

Browse the full library · About the Tower of Babel